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ABSTRACT 
 
 
 
Title:  Effects of high and low velocity muscle contraction on myosin heavy chain 
mRNA and protein expression in conjunction with muscle performance in the elderly 
Introduction:  Aging decreases skeletal muscle mass and contractile ability.  This 
decreases the capacity for an individual to successfully carry out activities of daily living, 
eventually leading to physical disability.  Recent research demonstrates that when 
compared to conventional resistance training, high velocity resistance training (HVRT) 
may be more effective in slowing or reversing age related declines in skeletal 
muscle.  However, there is currently a paucity of research which has aimed to investigate 
the transcriptional and translational events taking place within senescent skeletal muscle 
in response to HVRT. 
Purpose: To examine the velocity specificity of resistance training by directly comparing 
changes in muscle transcription, translation, performance, and function in older adults. 
Methods: Twenty-six older adults were randomized to partake in 6 weeks of either low 
velocity resistance training (LVRT) or HVRT. Subjects underwent pre- and post-training 
strength and functional testing.  A subsample of subjects also underwent subcutaneous 
needle biopsies of the vastus lateralis pre- and post-training. 
Results: From baseline to post-training, there were several significant (P < 0.05) 
differences in muscle performance and functional characteristics in LVRT (n = 13) and 
HVRT (n = 13) groups. Our results demonstrate HVRT provides a greater number of 
muscular enhancements when compared to LVRT, particularly under conditions of high 
velocity muscle contraction.  MyHc-a mRNA showed a significant (P < 0.01) decrease 
vi 
 
(.93-fold ± 0.12) in LVRT and a significant (P < 0.01) increase (2.0-fold ± .62) in 
HVRT.  MyHc-IIa mRNA showed a significant (P < 0.05) increase (1.2-fold ± 0.01) in 
HVRT.  MyHc-IIx mRNA showed a significant (P < 0.01) decrease (0.99-fold ± 0.004) 
in LVRT).  MyHc-b/slow had a significant (P< 0.05) decrease in HVRT (1.0 ± 0.12 vs 
0.84 ± 0.13, pre v post).  MyHc-IIx decreased (P < 0.01) in LVRT (1.0 ± 0.06 vs 0.87 ± 
0.06, pre vs post). 
Conclusion: HVRT is emerging as the optimal training stimulus for the older adult.  The 
present study demonstrates, in addition to increased muscular performance and functional 
outcomes, HVRT may also evoke a favorable (i.e., slow-to-fast) transcriptional and 
translational response in MyHC. 
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CHAPTER I   
INTRODUCTION 
 
 Inactivity, certain diseases, and aging decrease skeletal muscle mass and 
contractile ability.  This decreases the ability for an individual to successfully carry out 
activities of daily living (ADLs), eventually leading to physical disability (Guralnik, 
Ferrucci, Pieper, Leveille, Markides & Ostir, 2000; Janssen, Heymsfield & Ross, 2002; 
Kortebein, Ferrando, Lombeida, Wolfe & Evans, 2008).  Age-related declines in skeletal 
muscle mass was given the name sarcopenia (“sarcos” meaning flesh and “penia” 
meaning a lack of) and presents itself in a number of mammalian species (Brooks & 
Faulkner, 1988; Lexell, 1995; Rosenberg, 1989).  While no universal definition for 
sarcopenia exists, diagnostic criteria introduced by Baumgartner and colleagues (Koehler, 
Gallagher, Romero, Heymsfield, Ross, Garry & Lindeman, 1998) and Janssen et al. 
(2002) are commonly implemented.  Both methods utilize comparing relative amounts of 
muscle mass to total body mass, classifying individuals as sarcopenic if they fall 1 to 2 
(depending on the chosen diagnostic criteria) standard deviations below the mean of large 
sex specific reference populations.   
 Several mechanisms have been proposed to play a role in the decline of muscle 
mass and function with age:  endocrine changes, increased nuclear apoptosis, reduced 
satellite cell content /regeneration, muscle fiber denervation, oxidative stress, altered 
protein synthesis/proteolysis, changing contractile characteristics, decreased 
neuromuscular function, and increased content of muscular fat (Buford, Anton, Judge, 
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Marzetti, Wohlgemuth & Carter, 2010; Cruz-Jentoft, Vandewoude, Bauer, Baeyens, 
Zamboni & Topinkova 2010; Johnston, Lisio & Parise,  2008; Larsson & Ansved, 1995). 
 Findings from Janssen (2004) suggest 45% of the older U.S. population to be 
sarcopenic, while Manton (2001) report 20% of older adults in the U.S. are functionally 
disabled.  The impact of sarcopenia on the older adult population is far reaching.  
Individual and societal burdens include:  increased morbidity, disability, mortality and 
health care costs (Gale, Martyn, Cooper & Sayer, 2007; Sayer, Dennison, Syddall, 
Gilbody, Phillips & Cooper, 2005; Janssen et al., 2002; Janssen et al., 2004).  Janssen et 
al. (2004) report that healthcare costs directly attributable to sarcopenia in the U.S.  were 
$18.5 billion in 2000.  This figure will continue to rise as the percentage of older adults in 
the U.S is expected to increase from 11% to 20% by 2030 (National Institute on Aging 
and Statistics. 2007).  A 10% decrease in the prevalence of sarcopenia would result in a 
$1.1 billion saving per year in health care costs (Janssen et al., 2004).  Thus, reducing the 
prevalence and negative outcomes of sarcopenia is a critical challenge worthy of further 
investigation. 
 Declines in muscle mass in older adults seem to be primarily due to the loss and 
atrophy of Type-2 (fast) fibers (Nilwik, Snijders, Leenders, Groen, van Kranenburg, 
Verdijk & van Loon, 2013; Klitgaard, Mantoni, Schiaffino, Ausoni, Gorza, Laurent-
Winter, Schnohr & Saltin, 1990; Lexell et al. 1995), with the losses being most robust in 
the leg musculature (Janssen et al., 2000).  Supporting this notion, Verdijek, Koopman, 
Schaart, Meijer, Savelberg & van Loon (2007) reported 10% to 40% smaller Type-2 
fibers in older adults when compared to Type-2 fibers of young controls, with Type-1 
(slow) fiber size remaining relatively unchanged with age.    
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While muscle mass is an important factor influencing muscle strength (Visser, 
Goodpaster, Kritchevsky, Newman, Nevitt, Rubin & Harris, 2005), a growing body of 
literature demonstrates measures of muscular performance (e.g., muscular strength and 
power), which provide an indication of muscle quality (quality referring to the 
physiological functional capacity of muscle tissue), to be more effective in assessing 
mobility, functional status, and risk for morbidity and mortality in aging populations 
(Bassey, Fiatarone, O'Neill, Kelly, Evans & Lipsitz, 1992; Newman, Kupelian, Visser, 
Simonsick, Goodpaster, Kritchevsky & Harris, 2006).  Research indicates that when 
compared to skeletal muscle strength, measures of power have a greater influence on the 
capacity to perform ADLs, the risk of hip fracture, and mobility impairment (Bassey et 
al., 1992; Bean, Kiely, Herman, Leveille, Mizer & Frontera 2003; Phillips, Woledge & 
Bruce, 1998).  Progressively, this has led some to advocate for including declines in 
muscle quality and function in the diagnostic criteria for sarcopenia (Cruz-Jentoft et al., 
2010).   
Dynamic muscle strength is typically quantified by assessing either the maximal 
amount of force generated by a muscle or muscle group during a one repetition maximum 
(1RM) testing protocol, or the peak torque that can be developed against a lever that 
moves through an arc at a fixed angular velocity (isokinetic strength).   Muscular power 
is the product of the velocity and force of muscle contraction.  In older adults, peak 
power is generally achieved between 60% to 70% 1RM and at an angular velocity of 180 
deg/sec under isokinetic conditions (Cuoco, Callahan, Sayers, Frontera, Bean & Fielding 
2004; Fielding, LeBrasseur, Cuoco, Bean, Mizer & Singh, 2002).  
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Assessing muscle quality by testing muscular performance can serve as an 
important prognostic tool, as declines in muscle mass, strength, and power take place in a 
dissimilar fashion.  The median rate of muscle loss is reported to be 0.47% and 0.37% per 
year in older men and women, respectively (Mitchell, Williams, Atherton, Larvin, Lund 
& Narici, 2012).  Declines in muscle strength occur 2 to 5 times more rapidly than 
muscle mass, with the rate of decline in muscle power exceeding that of strength (Martin, 
Farrar, Wagner & Spirduso, 2000; Metter, Conwit, Tobin & Fozard 1997; Mitchell et al., 
2012).   Additionally, declines in power become more evident as movement speeds 
increase (Clark, Patten, Reid, Carabello, Phillips & Fielding, 2010) and the velocity at 
which peak power is generated also declines (Davies, White & Young, 1983; Martin et 
al., 2000; Pearson, Cobbold, Orrell & Harridge, 2006).  Several studies have 
demonstrated the independent influence of the velocity component of muscle power on 
functional performance, highlighting its importance (Bean, Kiely, LaRose, O’Neill, 
Goldstein & Frontera, 2009; Cuoco et al., 2004; Mayson, Kiely, LaRose & Bean 2008; 
Sayers, Guralnik, Thombs & Fielding, 2005).  It is likely that declines in the velocity and 
power generating capacity of skeletal muscle is influencing the increased risk of falls 
seen in older adults (Whipple, Wolfson & Amerman, 1987),  since powerful counter 
movements are frequently required for the prevention of falls (Pijnappels, Bobbert & 
Dieën, 2005).   
As the ability to produce quick and powerful movements degenerates more 
rapidly (Martin et al., 2000; Metter et al., 1997; Mitchell et al., 2012) and serve as better 
indicators for the capacity to successfully carry out ADL’s and future risk for impairment 
than strength (Bassey et al., 1992; Bean et al., 2003; Phillips et al., 1998), many 
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resistance training interventions have employed a training stimulus with an aim to 
enhance these abilities within the muscle groups being trained.  Early studies evaluating 
whether resistance training (RT) could improve skeletal muscle function utilized  low 
velocity resistance training (LVRT), involving slow contraction of skeletal muscles 
against “high” (relative to the maximal force generating capacity of the muscles 
performing work) loads.  LVRT commonly leads to hypertrophy, enabling a more 
forceful contraction to take place (Campos, Kraemer, Ratamess, Ragg, Murray & 
Hagerman 2002; Fiatarone et al., 1990; Kosek, Jeong-sur & Petrella, 2006; Taaffe, Pruitt, 
Pyka, Guido & Marcus, 1996; Trappe, Williamson & Godard, 2000; Trappe, Godard & 
Gallagher, 2001) and can reverse or slow some age-related declines within skeletal 
muscle (Campos et al., 2002; Mangione, Miller & Naughton, 2010; Kosek et al., 2006; 
Trappe et al., 2000, Trappe et al., 2001).  However, LVRT has been shown to be 
inadequate in improving the ability of older individuals to perform ADLs and provides 
only modest increases in muscular power (Bottaro, Machado, Nogueira, Scales & Veloso, 
2007; Fielding et al., 2002; Latham, Bennett, Stretton & Anderson, 2004), partly due to 
the low movement speeds employed (Henwood, Riek & Taaffe, 2008).    
The recognition of LVRT’s limitations led to the investigation of more powerful, 
higher velocity, movements during resistance training in older adults (Bottaro et al., 
2007; Earles et al., 2001; Fielding et al., 2002; Marsh et al., 2009; Puhke et al., 2006).  
This style of power, or high velocity resistance training (HVRT), is characterized by 
performing the concentric phase of each contraction as quickly as possible.  HVRT has 
been shown to enhance peak power and functional outcomes more effectively than LVRT 
(Earles et al., 2001; Fielding et al., 2002; Marsh et al., 2009; Puhke et al., 2006; Sayers & 
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Gibson, 2012; Sayers & Gibson, 2014).  Results from Earles et al. (2001) demonstrate 
increases of up to 141% in peak power after 12 weeks of HVRT in older adults, while 
Fielding et al. (2002) report an 84% greater increase in peak power in the HVRT group 
compared to LVRT.   
 In particular, trials investigating HVRT which have utilized movement speeds 
exceeding velocities of peak power production yield promising results, improving muscle 
quality and providing a real world carry over (Sayers et al., 2012; Sayers et al., 2014).  
This carry over seems to be related to increasing the velocity at which peak power is 
produced (Sayers et al., 2012; Sayers et al., 2014).  This noted enhancement in limb 
contraction velocity can benefit the older adult in many ways.  For an older individual 
carrying out ADLs, an emphasis is placed on force generating capabilities at the 
velocities required for carrying out a particular task (Pijnappels et al., 2005; Sayers et al., 
2012; Whipple et al., 1987).  Force development at these higher velocities will be the 
critical factor in determining if an older individual can move a lower limb rapidly enough 
to maintain safety in situations such as crossing the street, stabilizing the body to prevent 
a fall, or shifting a limb from a car accelerator to the break (Pijnappels et al., 2005; 
Sayers et al. 2012; Whipple et al., 1987).  From a practical outlook, most activities of 
daily living do not require maximal force or power development (Buchner et al., 1996).  
Moreover, it has been demonstrated that if one possesses the strength to complete a 
functional task, further strength gain does not inherently enhance functionality (Buchner 
et al., 1996).   
 The neural benefits of HVRT have been demonstrated (Van Cutsem, Duchateau 
& Hainaut, 1998).  However, there is currently a paucity of literature which has aimed to 
7 
 
investigate the transcriptional and translational events taking place within senescent 
skeletal muscle in response to HVRT.  Such work is of great importance since it can 
provide insights into the downstream mechanisms influencing older adults to respond 
favorably to a HVRT stimulus.   
The myofilament myosin heavy chain (MHC) serves as the molecular motor of a 
muscle fiber, completing the mechanical work necessary to elicit a muscle contraction 
(Bottinelli, Canepari, Pellegrino & Reggiani, 1996; Bottinelli, Pellegrino, Canepari, Rossi 
& Reggiani, 1999).  Classically, human muscle fibers have been known to express three 
MHC isoforms:  MHC-1, MHC-2A, and MHC-2X (Biral, Betto, Danielli-Betto & 
Salviati, 1998; Klitgaard et al., 1990).  Muscle fibers can express an exclusive isoform 
(pure fiber) or multiple isoforms (hybrid fiber), resulting in six different fibers types: 1, 
1/2A, 2A, 2A/2X, 2X, 1/2A/2X (Biral et al., 1998; Klitgaard et al., 1990).  Each myosin 
isoform has a unique set of contractile characteristics, with speed of contraction, tension, 
and power development increasing from:  MHC-1  MHC-2A  MHC-2X (Bottinelli 
et al., 1996; Bottinelli et al., 1999).  Of interest, is the isoform MyHC-, which was 
identified in an animal model and is thought to serve as an intermediate between MyHC-
/slow and MyHC-IIA in skeletal muscle (Peuker, Conjard & Pette, 1998).  It has been 
shown that a shift in the type of MHC isoform present within a muscle fiber can affect 
the contractile ability of that fiber and can also alter whole muscle performance 
(D’Antona, Lanfranconi, Pellegrino, Brocca, Adami & Rossi, 2006; Harridge et al., 1996; 
Ryushi & Fukunaga, 1986).   
 While a preponderance of work demonstrates RT and endurance exercise results 
in a fast-to-slow shift in MHC protein and mRNA (MHC-2X MHC-2A)  (Hortobagyi, 
8 
 
Hill, Houmard & Fraser, 2000; Short, Vittone & Bigelow, 2005; Staron et al., 1990), 
research which has applied a sprint or high velocity training stimulus found a slow-to-fast 
(MHC2A   MHC2X)  or bidirectional (MHC-1 MHC-2A MHC2X) shift in 
histochemical and biochemical properties and mRNA (Andersen et al., 1994; 
Esbjornsson, Hellsten-Westing, Balsom, Sjödin, & Jansson 1993; Jansson et al., 1978; 
Jansson et al., 1990; Liu, Schlumberger, Schmidtbleicher & Steinacker, 2003; Malisoux 
et al., 2006; Paddon-Jones, Lonergan, Abernethy & Leveritt 2001).  Paralleled with this 
slow-to-fast shift in MHC are training adaptations which have proven to be favorable in 
older adults, such as increases in movement speed, peak power, and the velocity at which 
peak power takes place.   Consequently, the purpose of this study was to investigate the 
transcriptional and translational events which occur in older adults in response to HVRT, 
since the information gained has the potential to elucidate a mechanism underlying the 
noted favorable training adaptations.    
The hypotheses for this study were that HVRT would induce a slow –to-fast shift 
in MHC composition and lead to a greater number of favorable muscle performance 
outcomes, when compared to LVRT 
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CHAPTER II  
 
 REVIEW OF LITERATURE 
 
 
Sarcopenia 
 The progressive decline in muscle mass, strength and functionality associated 
with aging is known as sarcopenia (Cruz-Jentoft et al., 2010).  This noted decline in 
muscle mass, strength and size with age is well documented in a range of mammalian 
species (Brooks et al., 1988; Lexell et al., 1995). 
 Depending on the definition used for sarcopenia, the prevalence in people 60 to 
70 years old is 5 to 13%, while the prevalence ranges from 11 to 50% in people >80 years 
in the United States (Morley et al., 2008).  However, considerable disparity exists when 
quantifying the prevalence of sarcopenia in older populations as a result of various 
definitions and criteria for classification. While no universal definition for sarcopenia 
exists, diagnostic criteria introduced by Baumgartner et al. (1998) and Janssen et al. 
(2002) are commonly implemented.  Both utilize comparing relative amounts of muscle 
mass to total body mass.  The method proposed by Baumgartner et al. (1998) utilizes a 
measure of relative amounts of muscle mass by dividing absolute muscle mass, 
(quantified by dual-energy X-ray absorptiometry (DXA)) by height squared, with 
sarcopenia being defined as relative muscle mass being more than two standard 
deviations below the mean of a large sex specific reference population.  The method 
proposed by Janssen et al. (2002) utilizes a skeletal muscle index (SMI), dividing total 
muscle mass (attained via bioelectrical impedance analysis (BIA)) by total body mass, 
classifying sarcopenia as being between one and two standard deviations below young 
adult values. 
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 Findings from Janssen and colleagues (2004) suggest 45% of the older U.S. 
population to be sarcopenic, while Manton and colleagues (2001) report 20% of older 
adults in the U.S. are functionally disabled.  The impact of sarcopenia on the older adult 
population is far reaching. Individual and societal burdens include:  increased morbidity, 
disability, mortality and health care costs (Gale et al., 2007; Sayer et al., 2005; Janssen et 
al., 2002; Janssen et al., 2004).  Janssen and colleagues (2004) report that healthcare costs 
directly attributable to sarcopenia in the U.S. was $18.5 billion in 2000.  This figure will 
continue to rise as the percent of older adults in the U.S is expected to increase from 11% 
to 20% by 2030 (National Institute on Aging and Statistics).  A 10% decrease in 
prevalence of sarcopenia would result in a $1.1 billion saving per year in health care costs 
(Janssen et al., 2004). Thus, reducing the prevalence and negative outcomes of sarcopenia 
is a critical challenge, worthy of further investigation.   
 The etiology and progression of sarcopenia is multi-faceted.  Several mechanisms 
have been proposed to play a role:  increased nuclear apoptosis, reduced satellite cell 
content / regeneration, muscle fiber denervation, oxidative stress, altered protein 
synthesis/proteolysis, decreased neuromuscular function, and increased content of 
muscular fat (Buford et al., 2010; Cruz-Jentoft et al., 2010; Johnston et al., 2008; Larsson 
et al., 1995).    
Fiber type delineation (histochemical, immunohistochemical, and electrophoretic 
techniques) 
 Dating back to 1678, attempts have been made to classify skeletal muscle fiber 
types (Nowak et al., 2008).  Initially, fiber types were grossly classified as red and white 
based on their hue due to varying magnitudes of myoglobin (Nowak et al., 2008).  
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Improvements in nomenclature came about with the classification of fibers based on 
contractile characteristics (slow and fast twitch) and metabolic pathway utilization 
(glycolytic and oxidative) (Nowak et al., 2008).   
 More sophisticated methods were developed in order to analyze fiber types based 
on enzymatic histochemical reactions, such as myofibrillar ATPase (mATPase) staining 
(Brooke et al., 1970).  During the cross-bridge cycle, the myosin molecule binds and 
hydrolyzes ATP during force generation, and because myosin ATPase activity is 
positively correlated with muscle contraction velocity, measures of ATPase activity can 
be interpreted in terms of contraction speed (Nelson et al., 2008).  Staining for ATPase 
results in differentiation of muscle types by color based on the pH of the preincubation 
solution.  This process reveals a spectrum of fibers:  Type-1  Type-2A  Type-2C  
Type-2X (Nowak et al., 2008).  This hierarchy reflects increases in contractile and 
glycolytic capacity as levels of ATPase increase from Type-1  Type-2X.   While 
mATPase histochemistry provided further insight into varying fiber type characteristics 
(Staron et al., 1991), biochemical truths cannot be ascertained from histochemistry 
(Brooke et al., 1974).   
 Electrophoretic techniques are utilized to separate protein molecules by size and 
can detect Myosin Heavy Chain (MHC) levels as low as 2–3% of the protein content 
(Giulian et al., 1983).  Three electrophoretically distinct MHC isoforms, termed MHC-1, 
MHC-2A and MHC-2X, have been identified by sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis (PAGE) (Biral et al., 1998).    
 Present day immunohistochemical techniques, such as the western blot, utilize 
antigen-antibody techniques to identify specific proteins, even in very small amounts, 
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within a tissue sample (Brooke et al., 1974).  Immunohistochemistry has been used to 
identify many proteins which play pivotal roles in the structure and function of muscle 
fibers (Nowak et al., 2008).  This technique was implemented in the identification of the 
motor protein MHC and its isoforms (Nowak et al., 2008).  Following electrophoretic 
separation, MHC identification via antibody probing is currently the most valid method 
for fiber typing (Schiaffino et al., 2011). Unlike several other mammalian species, in 
human muscles, MHC-2B is not detectable, although the corresponding MYH4 gene is 
present in the genome (Smerdu et al., 1994).  In addition to pure fiber types, which 
express a singular MHC isoform, human skeletal muscles contain a significant proportion 
of fibers with hybrid myosin composition.  Most commonly, these hybrid fibers co-
express MHC-1 with MHC-2A or MHC-2A with MHC-2X (Biral et al., 1998; Klitgaard 
et al., 1990).  
Functional diversity among fiber types 
 There is considerable functional diversity between fiber types and accompanying 
sub-types (Bottinelli et al., 1996; Bottinelli et al., 1999).  The extent to which a given 
MHC isoform is expressed within a muscle fiber influences contractile capacity and rate 
of ATP utilization (Bottinelli et al., 1996; Bottinelli et al., 1999; Schiaffino et al., 2011).    
 The functional capacity of an activated muscle fiber is quantified through 
measures of force, velocity, and power.  The force generating capacity of a half-
sarcomere during an isometric contraction can be represented as the number of strongly 
bound cross bridges (XB) between actin and myosin multiplied by the force generated 
per XB (Funi) (Brenner, 1988).   The number of strongly bound XBs at a given point in 
time is determined by the total number of functional myosin heads (N) multiplied by the 
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fraction of time a strongly bound XB is formed (ton) as a function of total myosin cycle 
time (ton + toff), where ton is the amount of time myosin is strongly bound to actin and toff 
is the amount of time myosin is detached from actin.  The amount of force that can be 
produced in the half sarcomere under isometric conditions can be expressed as:  N 
(ton/(ton+toff))Funi.  Force generated per XB interaction is also dependent upon the elastic 
stiffness of the XB (kstiff) multiplied by the unitary displacement of the power stroke 
(duni).   
 The maximum isometric force per unit cross-sectional area, or specific tension 
(Po/CSA), is approximately 2 times lower in Type-1 fibers than Type-2A and Type-2X, 
with no significant difference being reported between the fast fiber types (Bottinelli et al., 
1996; Bottinelli et al., 1999).  Two factors contribute to the higher force development in 
fibers expressing fast MHC isoforms compared with those expressing slow isoforms:  a 
greater number of strongly attached myosin heads and higher force development (Funi) 
per myosin head (Brenner, 1988; Linari et al., 2004).  Contractile velocity is determined 
by duni divided by ton, with a shorter ton representing a higher myosin detachment rate 
(Wallcot et al., 2012) and is exemplified in the differing contraction speeds of human 
myosin isoforms.  In humans, fibers comprised of MHC-2X (Type-2X fast fiber) display 
up to 9 times greater unloaded shortening velocity (V0), and maximal power (Wmax) 
output than those with a MHC-1 (Type-1 slow fiber) composition (Bottinelli et al., 1996; 
Bottinelli et al., 1999).  Fibers comprised of MHC-2A (Type-2A fast fiber) display 
intermediate V0 and Wmax outputs (Bottinelli et al., 1996; Bottinelli et al., 1999).  Trappe 
et al., (2003) report Type-2 fibers generate four to six times more power than Type-1 
fibers.   
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 Quantifying maximal rates of Vo and Po are of consequence since they set the 
ceiling for other contractile parameters (Bottinelli et al., 1999).  However, in vivo, 
muscles rarely contract isometrically, and never contract against zero load.  This being 
the case, other performance variables need to be considered to get a clearer idea of a 
muscle fiber’s in vivo capacity.  Power output, a measure of mechanical energy released 
per unit of time, is a more meaningful performance variable in relation to in vivo muscle 
performance (Bottinelli et al., 1999; Schiaffino et al., 2011).  A muscle fiber’s peak 
power (Wmax) is determined by the maximum velocity of unloaded shortening (V max 
when determined from the force velocity curve or Vo when determined with the slack 
test), the isometric force (Po), and the curvature of the relationship. The less the 
curvature, the greater the force generated at a particular velocity, resulting in a greater 
power output (Bottinelli et al., 1999; Schiaffino et al., 2011).  This places an emphasis on 
the shortening velocity and the amount of force developed when peak power is reached 
within a muscle fiber.  These values are termed optimal velocity and optimal force. 
Optimal velocity (Vopt) is reached at ~20% Vo in fast fibers and ~15% Vo in slow fibers, 
resulting in Vopt being about four times higher in fast fibers than in slow fibers 
(Bottinelli et al., 1999).  In vivo, Vopt has been shown to be the velocity preferentially 
adopted during movement, which suggests fibers are recruited not only on the need to 
increase force development but also in relation to the speed at which a movement must be 
performed (Lutz et al., 1994; Rome et al., 1988).   
 These fiber type characteristics are further expressed at the motor unit level.  Fast 
motor units produce 10 to 20 times greater isometric tension than slow motor units 
(Henneman et al., 1981).  Being that a fast motor unit contains a larger amount of fibers, 
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and fast fibers produce up to 9 times greater power outputs than slow fibers, a fast motor 
unit will produce a power output hugely surmounting that of a slow motor unit (Bottinelli 
et al., 1999).  Outside of peak power values, a motor unit which is comprised of fast 
fibers can effectively maintain force development at velocities which surpass that of peak 
power development (Bottinelli et al., 1999).   
 In essence, if one is to produce large amounts of force rapidly, it will come from 
recruiting fast motor units (Henneman et al., 1981; Bottinelli et al., 1996; Bottinelli et al., 
1999).   The contractile profile of these fast motor units (i.e., to what degree they are 
composed of MHC-2A or MHC-2X) will influence the amount of force that can be 
generated at a given velocity (Bottinelli et al., 1996; Bottinelli et al., 1999; Pearson et al., 
2006).   
 Of note, while the fast fiber types do not differ significantly in (Po/CSA), they 
vary significantly in every other quantifiable performance variable.  In fact, greater 
heterogeneity can be displayed between Type-2A and Type-2X than between Type-1 and 
Type-2A fibers (Bottinelli et al., 1999).  This highlights how distinct each of the myosin 
heavy chain isoforms are from one another, as well as the importance of classifying fiber 
types based on the particular fast MHC isoforms which are present, and not defaulting to 
a Type-1 or Type-2 classification.   
Type-2 fiber atrophy and functional consequences 
 In aging human populations, declines in muscle mass seem to be primarily due to 
the atrophy of Type-2 fibers, with the losses being most robust in the leg musculature 
(Janssen et al., 2000; Nilwik et al., 2013; Klitgaard et al., 1990; Lexell et al. 1995).  
Supporting this notion, Verdijek and colleagues (2007) reported 10 to 40% smaller Type-
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2 fibers when compared to young controls, with Type-1 fiber size remaining relatively 
unchanged.  Kosek and colleagues (2006) demonstrate a robust atrophy of Type-2X 
fibers with age.  Decrease in Type-2 fiber CSA decreases force generating capacities 
within the muscle (Trappe et al., 2003).   
 Transcriptional and translational events have been investigated in search for a 
mechanism underlying Type-2 fiber atrophy with age. The effects of aging on the 
transcription and translation of MHC isoforms are functionally important, since MHC 
serves as the molecular motor of a muscle fiber, completing the mechanical work 
necessary to elicit a muscular contraction (Schiaffino et al., 2011).  Translation is affected 
by a decrease in the rate of MHC-2A and MHC-2X synthesis (Blazejowski et al., 1984, 
Hasten et al., 2000; Welle et al., 1993).   Declines in MHC contraction characteristics 
have also been reported with age (Hook et al., 1999; Larsson et al., 1997).  However, 
conflicting results have been reported (Trappe et al., 2003).   
 MHC-1 transcript levels remain relatively static with age (Balagopal et al., 2001; 
Welle et al., 1996).  However, aging’s effects on MHC-2A and MHC-2X transcription 
are not as well understood.   Welle and colleagues (1996) reported no differences in 
MHC-2A and MHC-2X mRNA levels between young and old men and women.  
However, a decrease in MHC-2A mRNA, but not in MHC-2X mRNA, has been observed 
in old men (Welle et al., 2000). Balagopal and colleagues (2001) further reported 
significant decreases in both MHC-2A and MHC-2X mRNA with aging in men and 
women.  The decreased MHC-2A and MHC-2X mRNA levels reported by Welle and 
colleagues (2000) and Balagopal and colleagues (2001) provide a logical mechanism 
underlying the decreased synthesis of fast MHC isoforms within senescent muscle tissue.  
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 The equivocal results reported when investigating MHC mRNA could be partly 
due to the absence of quantifying MHC isoform expression at the protein level.  While 
the protein isoform and corresponding mRNA share an association, normalizing MHC 
mRNA to MHC protein is paramount (Hortobagyi et al. 2000; Periasamy et al., 1989).  
This is because there is significant variability in skeletal muscle MHC isoform expression 
between individuals as a result of genetic and environmental influence (Simoneau et al., 
1995).   
 When considering the fundamental characteristics of the MHC isoforms, it comes 
as no surprise that this preferential loss of MHC-2A and MHC-2X (Type-2 fibers) is 
directly related to decreases in power producing capacities which greatly exceed muscle 
loss in older populations (Davies et al., 1983; Martin et al., 2000; Metter et al., 1997; 
Trappe et al., 2003).   Declines in power production become more evident as movement 
speeds increase (Clark et al., 2010).  The angular velocity at which peak power is 
generated (Vopt) is also reduced (Davies et al., 1983; Martin et al., 2000; Pearson et al., 
2006).   It is likely that this decline in velocity and power generating capacity within the 
muscle is influencing the increased risk of falls seen in older adults (Whipple et al., 
1987), as it has been demonstrated that powerful counter movements are frequently 
required for the prevention of falls (Pijnappels et al., 2005).  Further risks of muscle 
weakness include immobility, dependency, and disability (Fiatarone et al., 1990).  
MHC isoforms and mRNA in transition 
 Skeletal muscle is a heterogeneous tissue with an incredible propensity to adapt to 
the stimulus it is placed under (Canepari et al., 2005; Schiaffino et al., 2011).  Alterations 
of myosin heavy chain isoform composition within the muscle can, in part, explain the 
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muscular adaptations achieved through exercise (Canepari et al., 2005; Schiaffino et al., 
2011). 
 Shifts in the expression of MHC at the protein and mRNA levels can vary greatly 
in response to patterns of mechanical loading or deloading (Larsson et al., 1985; Short et 
al., 2005).   Longitudinal studies have documented a slow to fast transformation (MHC-I 
 MHC-2A  MHC-2X) under conditions of immobilization or detraining (Haggmark 
et al., 1986; Larsson et al., 1985) and a fast to slow transformation (MHC-2X MHC-
2A  MHC-1) as a result of endurance exercise (Howald et al., 1985; Short et al., 2005).  
 The MHC-I  MHC-2A  MHC-2X shift in response to immobilization or 
detraining has led to characterizing Type-2X fibers as “default fibers” which will respond 
to any form of mechanical loading in a MHC-2X MHC-2A (fast to slow) fashion.  A 
preponderance of works demonstrates resistance and endurance exercise leading to the 
noted response: MHC-2X MHC-2A in MHC protein and mRNA (Hortobagyi et al., 
2000; Short et al., 2005; Staron et al., 1990).   However, the direction of shifting seen in 
MHC at the protein and mRNA level seem to be highly dependent upon the training 
stimulus (Andersen et al., 1994; Esbjornsson et al., 1993; Jansson et al., 1978 Jansson et 
al., 1990; Liu et al., 2003; Malisoux et al., 2006; Paddon-Jones et al., 2001).  Research 
employing a high velocity training stimulus has induced a slow to fast shift in 
histochemical properties (Esbjornsson et al., 1993; Jansson et al., 1978 Jansson et al., 
1990; Paddon-Jones et al., 2001) and MHC isoforms (Liu et al., 2003).  Others have 
demonstrated an increase in MHC-2A, with no decrease in MHC-IIX or a bidirectional 
shift towards MHC-2A (Andersen et al., 1994; Malisoux et al., 2006).   
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 During states of training or detraining, the presence of hybrid fibers (fibers co-
expressing MHC-1 with MHC-2A or MHC-2A with MHC-2X) are a common finding 
(Andersen et al., 1997; Marx et al., 2002).  Andersen and colleagues (1997) suggest 
hybrid fibers are generally present when fiber type transition occurs.  Under these 
conditions, hybrid fibers will display a mismatch between the distribution of MHC 
mRNA and protein isoforms (Andersen et al., 1997; Marx et al., 2002).  In response to 
training and detraining, Andersen and colleagues (1997) demonstrate mismatched fibers 
representing transitional fibers at various stages of the transformation process.  This 
mismatch can be utilized in clarifying the direction in which the fiber is shifting.  The up-
or-down regulation of mRNA will occur first in a transitional process (MHC mRNA first 
in, first out) with protein changes following (MHC protein last in, last out) (Andersen et 
al., 1997; Marx et al., 2002).  In other words, when transformation is initiated there will 
be upregulation of mRNA which expresses the direction of the current shift, but the 
corresponding protein will not be expressed, while the mRNA and protein of the original 
fiber type will still be expressed (Andersen et al., 1997).  During the intermediate stages 
of the transitional process, a better match between the distribution of MHC mRNA and 
protein is expected (Andersen et al., 1997).  During the final phase of transformation, 
both the newly induced mRNA and protein should be detected, as well as the protein but 
not the mRNA of the original fiber type (Andersen et al., 1997).  This is in response to a 
more rapid turnover of MHC mRNAs, compared with the slow turnover of the 
corresponding proteins (Gupta et al., 1992; Russell et al., 1992). 
 It has been reported that the delayed appearance of new MHC isoforms is not due 
to delayed synthesis, but delayed incorporation of the isoforms into the sarcomere (Pette 
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et al., 1992).  This delay is thought to be caused by the disassembling of older filaments 
before newly synthesized isoforms are introduced into the sarcomere (Brown et al., 1989; 
Eisenberg et al., 1984).  This inherent delay of MHC incorporation would be amplified in 
the older adult due to decreased rates of MHC-2A and MHC-2X synthesis (Blazejowski 
et al., 1984, Hasten et al., 2000; Welle et al. 1993).  This suggests, if a study were not 
long enough in duration, expression of new MHC isoforms may not be detected, even if 
there were increased expression at the mRNA level.  This highlights the importance of 
investigating mRNA expression in situations where MHC shifting would be expected.   
Furthermore, normalizing MHC mRNA to MHC protein expression allows control of the 
variability seen from person to person in MHC isoform expression at the protein level 
(Simoneau et al., 1995).  Increases in MHC mRNA occur rapidly at the onset of training 
and have a half-life up to 3 days post training (Nadal-Ginard et al., 1982), with 
corresponding proteins having a half-life of 2-3 weeks (Bates et al., 1983).   
Low velocity resistance training (LVRT) 
 Early studies evaluating whether resistance training (RT) could improve skeletal 
muscle function utilized  low velocity resistance training (LVRT) (i.e., slow contraction) 
of skeletal muscles against “high” (relative to the maximal force generating capacity of 
the muscles performing work) loads.  This low velocity style of training commonly leads 
to hypertrophy, enabling a more forceful contraction to take place (Campos et al., 2002; 
Fiatarone et al., 1990; Kosek et al., 2006, Taaffe et al., 1996 Trappe et al., 2000; Trappe 
et al., 2001) and can reverse or slow some age-related declines within muscle tissue 
(Campos et al., 2002; Kosek et al., 2006; Mangione et al., 2010; Widrick et al., 2001).  
However, LVRT has been shown to be inadequate in improving the ability of older 
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individuals to perform activities of daily living and provides only modest increases in 
muscular power (Earles et al., 2001; Latham et al., 2004).  The lack of carry over into real 
world situations is in part due to the low movement speeds employed (Henwood et al., 
2008).    
High velocity resistance training (HVRT) 
  The recognition of LVRT’s limitations led to the investigation of more powerful, 
higher velocity, movements during resistance training in older adults (Bottaro et al., 
2007; Earles, 2001; Fielding et al., 2002; Marsh et al., 2009; Puhke et al., 2006).  This 
style of power, or high velocity, resistance training (HVRT), is characterized by 
performing the concentric phase of each contraction as quickly as possible and has been 
shown to enhance peak power and functional outcomes more effectively than low 
velocity training (Earles, 2001; Fielding et al., 2002; Marsh et al., 2009; Puhke et al., 
2006 Sayers et al., 2012 Sayers et al., 2014).  In particular, utilizing movement speeds 
which exceed velocities of peak power generation demonstrate promising results for 
improved function and real world carry over (Sayers et al., 2012).  This carry over seems 
to be, in part, explained by increasing the velocity at which peak power is generated 
(Sayers et al., 2012; Sayers et al., 2014).  This noted enhancement in limb contraction 
velocity can benefit the older adult in many ways:  for an older individual carrying out 
ADL’s, an emphasis will be placed on the level of force generation one is capable of at 
the velocities required for carrying out a particular task (Pijnappels et al., 2005; Sayers et 
al., 2012; Whipple et al., 1987).  Force development at these higher velocities will be the 
critical factor in determining if an older individual can move a lower limb rapidly enough 
to maintain safety in situations such as crossing the street, stabilizing the body to prevent 
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a fall, or shifting a limb from the accelerator to the break (Pijnappels et al., 2005; Sayers 
et al. 2012; Whipple et al., 1987).  From a practical outlook, most activities of daily 
living do not require maximal force or power development (Buchner et al., 1996).  
Furthermore, it has been demonstrated that if one possesses the strength to complete a 
functional task, further strength gain does not inherently enhance functionality (Buchner 
et al., 1996).   
Conclusion 
The neural benefits of HVRT have been demonstrated (Van Cutsem et al., 1998).  
However, there is currently a paucity of literature which has aimed to investigate the 
transcriptional and translational events taking place within senescent skeletal muscle in 
response to HVRT.  Such work is of great importance since it can provide insights into 
the mechanisms influencing older adults to respond favorably to a HVRT stimulus.   
The myofilament myosin heavy chain (MHC) serves as the molecular motor of a 
muscle fiber, completing the mechanical work necessary to elicit a muscle contraction 
(Schiaffino et al., 2011).   Human muscle fibers express three MHC isoforms:  MHC-1, 
MHC-2A, and MHC-2X (Biral et al., 1998; Klitgaard et al., 1990).  Muscle fibers can 
express an exclusive isoform (pure fiber) or multiple isoforms (hybrid fiber), resulting in 
six different fibers types: 1, 1/2A, 2A, 2A/2X, 2X, 1/2A/2X (Biral et al., 1998; Klitgaard 
et al., 1990).  Each myosin isoform has a unique set of contractile characteristics, with 
speed of contraction, tension and power development increasing from:  MHC-1  MHC-
2A  MHC-2X (Bottinelli et al., 1996; Bottinelli et al., 1999).  A shift in the type of 
MHC isoform present within a muscle fiber will impact the contractile ability of that fiber 
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and can also alter whole muscle performance (D’Antona et al., 2006; Harridge et al., 
1996; Ryushi et al., 1986).   
 While a preponderance of work demonstrates RT and endurance exercise leads to 
a fast- to-slow shift in  in MHC protein and mRNA (MHC-2X MHC-2A)  (Hortobagyi 
et al., 2000; Short et al., 2005; Staron et al., 1990), studies which have applied a sprint or 
high velocity training stimulus have led to a slow-to-fast (MHC2A   MHC2X)  or bi 
directional (MHC-1 MHC-2A MHC2X) shift in MHC protein and mRNA 
(Andersen et al., 1994; Esbjornsson et al., 1993; Jansson et al., 1978 Jansson et al., 1990; 
Liu et al., 2003; Malisoux et al., 2006; Paddon-Jones et al., 2001).  Paralleled with this 
slow to fast shift in MHC are training adaptations which have proven to be favorable in 
aging populations: increases in movement speed, peak power, and the velocity at which 
peak power takes place.   If a slow to fast shift in MHC protein and mRNA also presents 
itself in older adults in response to HVRT is worthy of investigation, as it aids in 
elucidating a mechanism underlying the noted favorable training adaptations.  
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CHAPTER III   
 
METHODS AND MATERIALS 
 
 
Subjects 
 
 Subjects were recruited from the Ames, IA.  area through advertisements and 
email.  Potential subjects were initially screened by telephone or in person.  To be 
eligible for the training portion of the study, subjects needed to be aged 60 and older, 
ostensibly healthy, and not have participated in structured progressive resistance training 
within the prior 6 months.  Exclusion criteria included any preexisting condition that 
would inhibit successful participation in the exercise program, such as cardiovascular 
disease, musculoskeletal disorders, and neurological, or cognitive impairment.  Exclusion 
criteria for the biopsy portion of the studyincluded cardiovascular, neurological or 
musculoskeletal disease; a history of bleeding disorders; taking any anticoagulant (blood-
thinning) medications or other medications that affect blood clotting.  Written, informed 
consent was obtained from each participant after all procedures were approved by the 
Institutional Review Boards of Iowa State University.  Gender, age, height, body weight 
and BMI were recorded (Table 1).  The racial distribution of the participants was 100% 
Caucasian. 
 
Table 1.  Anthropometric data 
         Group n n (f) n (m) Age (yr) Height (cm) Body Weight (kg) BMI 
 LVRT 13 8 5 65.1 ± 1.8 171.1 ± 2.2 80.0 ± 2.8 27.3 ± 1.1 
 HVRT 13 8 5 64.5 ± 0.7 170.4 ± 2.2 79.1 ± 4.8 27.1 ± 1.3 
 Values are means ± SE; LVRT, low velocity resistance training; HVRT, high velocity resistance 
training; n, number of subjects; f, female; m, male; BMI, body mass index 
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Study design 
 
 Subjects were randomized to partake in 6 weeks of low velocity resistance 
training (LVRT) or 6 weeks of high velocity resistance training (HVRT) (details below).  
Subjects underwent pre-and-post training strength and functional testing (details below).  
A subsample of subjects also underwent subcutaneous needle biopsies of the vastus 
lateralis pre-and-post training (details below).  The first visit that subjects made to the lab 
was a familiarization session.  The following visit was to undergo the initial muscle 
biopsy procedure. Three days later, subjects came in for baseline strength and functional 
testing.  Two days after this, subjects began 6 weeks of training.  Two days after the final 
training session, subjects came to the lab for the final biopsy procedure.  Two to three 
days later subjects came in for post-training strength and functional testing.  No subjects 
missed more than 2 training sessions throughout the 6 week training period.  Subjects 
were asked to maintain all prior physical activity and dietary habits and not to partake in 
any form of lower body resistance training outside of the study. 
 Progressive Resistance Training:  Resistance training was performed 3 times per 
week for 6 weeks.  Each resistance training session was separated by at least 48 hours.  
Resistance training sessions consisted of performing unilateral knee extensions for both 
lower limbs.  The target muscles were the knee extensors (vastus intermedius, vastus 
medialis, vastus lateralis and rectus femoris).  Subjects performed 3 sets of 8 repetitions, 
consecutively, for each leg on a calibrated Biodex Multi-Joint System Pro dynamometer 
(Biodex Medical Systems, Shirley, NY).   Subjects assigned to LVRT performed each 
repetition at an angular velocity of 75 degrees/second.  Subjects assigned to HVRT 
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performed each repetition at an angular velocity of 240 degrees/second.  The interval 
between repetitions and sets was 3 to 4 s and 3 min, respectively.  
Muscle performance measurements 
  
 Isokinetic Strength Testing Procedure:   Concentric, isokinetic knee extensions 
were performed on the dominant leg at ordered velocities of 75, 180, and 240 deg/sec.  
Outputs for peak torque, max rep work, total work, torque at .2 sec, the rate of force 
development, average power and peak power were measured at each velocity using a 
calibrated dynamometer (Biodex Medical Systems, Shirley, NY). Subjects were seated 
with a restraining strap over the pelvis and trunk in accordance with the Biodex User’s 
Guide.  The input axis of the dynamometer was aligned with the axis of the knee, and the 
non-working leg was braced against the contralateral- limb stabilization bar. Three 
submaximal warm-up trials preceded 3 maximal muscle actions at each velocity, with the 
highest value selected as the representative score. A 4-minute rest was allowed between 
testing at each velocity.  
Functional measurements 
 
 Balance: Tandem, semi-tandem and side by side stands:  For each stand, the test 
administrator first demonstrated the task, then supported one arm while participants 
positioned their feet, asked if they were ready, then released the support and began 
timing.  The timing was stopped when the participants moved their feet or grasped the 
interviewer for support, or when 10 seconds had elapsed.  Each participant began with the 
semi-tandem stand, in which the heel of one foot was placed to the side of the first toe of 
the other foot, with the participant choosing which foot to place forward.  Those unable 
to hold the semi-tandem position for 10 seconds were evaluated with the feet in a side by 
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side position.  Those able to maintain the semi-tandem position for 10 seconds were 
further evaluated with the feet in full tandem position, with the heel of one foot directly 
in front of the other (Guralnik et al., 2000).  
 Usual walking speed:  Subjects were instructed to perform three bouts of 4-m 
walking at a usual (“As if you were walking down the street to go to the store”) speed.  
Time to completion was recorded using a stop watch. Trials were separated by 2 minutes.  
The fastest time to completion was used for analysis (Guralnik et al., 2000). 
 Maximal walking speed: Subjects were instructed to perform three maximum 
effort bouts of 4-m walking, beginning 2-m before the start line in order to achieve 
optimal speed. Time to completion was recorded using a stop watch.  Trials were 
separated by 3 minutes.  The fastest time to completion was used for analysis (Guralnik et 
al., 2000). 
 Sit-to-stand test:  A straight-backed chair was placed next to a wall.  Subjects 
were asked to fold their arms across the chest and to stand up from a seated position on 
the chair. From the sitting position, the subject stood up to full height, then completely 
back down.  After this was completed, the subject was instructed to stand up and sit down 
five times as quickly as possible Time to completion was recorded using a stop watch.  
Trials were separated by 3 minutes.  The fastest time to completion was used for analysis 
(Guralnik et al., 2000).   
 Get-up and go:  Subjects were instructed to sit on a chair with their back straight, 
feet flat on the floor, and hands on their thighs.  The timer was started on the signal “go,” 
whether or not the participant actually started to move, and terminated when the subject 
covered 8 ft. and sat back down. The procedure was visually demonstrated in advance, 
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and each participant was allowed to practice it once. Following the practice, three test 
trials were administered. Time to completion was recorded using a stop watch.  Trials 
were separated by 3 minutes.  The fastest time to completion was used for analysis (Rikli 
and Jones, 1999). 
Biochemical measurements 
 
 Muscle biopsy:  A percutaneous biopsy was obtained using a 5mm Bergström 
needle, under local anesthesia from the vastus lateralis muscle of the dominant leg.  The 
muscle samples (~40 mg of tissue) were removed, immediately frozen in liquid nitrogen 
and then stored at -80°C.  Biopsies were obtained at rest and on non-training days, 3 to 4 
days before baseline testing and 2 days after the final training session.  The post training 
biopsy was obtained from the same leg, 3–4 cm distal to the site of the pre training 
biopsy. 
 RNA isolation and qRT-PCR:  Muscle samples were powdered with a dry-ice-
chilled mortar and pestle. Total RNA was extracted from ~30 mg of powdered muscle 
using TRIizol (Invitrogen, Carlsbad, CA, USA), following the manufacturer’s 
instructions.  Powdered muscle was homogenized with a handheld homogenizer in 
TRIzol reagent, centrifuged and extracted with chloroform, and precipitated with ethanol. 
Total RNA was DNase treated (RNaseFree DNase set, Qiagen Inc., Valencia, CA; cat. no 
79254) and purified using a column (RNeasy kit, Qiagen Inc.; cat. no 74106) to remove 
potential genomic DNA contamination.  RNA concentration and purity was determined 
using an ND-1000 Spectrophotometer (λ = 260/280 nm; NanoDrop technologies, Inc., 
Wilmington, DE). Total RNA (60ng/μl) was reverse transcribed to cDNA utilizing the 
Superscript III One-Step qPCR (Qiagen).  cDNA was diluted (1:20) in RNase-free water.  
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Diluted cDNA (2 μl) was amplified on an Eppendorf PCR Master cycler using Quantitect 
SYBR Green PCR kit (Qiagen).  Primers for Myh7, Myh6, Myh2, Myh1 and Actb were 
designed by Primer 3 Input Version (0.4.0) and are listed in Table 2.  The regular cycling 
program consisted of a 15-min hold at 95 °C and 45 cycles of denaturing at 95 °C for 15 
s, annealing at 58 °C for 15 s, and extension at 72 °C for 20 s at which point data were 
acquired.  Gene expression was determined using the 2−ΔΔCt method (Livak et al., 
2000).  Delta (Δ) CT values were calculated by subtracting the CT value from the 
experimental gene from the CT value of the control. These values were used for 
statistical comparisons. ΔΔCT was calculated by subtraction of the ΔCT of a treated 
muscle from the ΔCT of the corresponding control.  Each sample was normalized to Actb 
before quantification. 
 Protein extraction:  Protein was isolated from the interphase and phenol-
chloroform layer saved from RNA isolation.  Briefly 300 µl of 100% ethanol was added 
to phenol-chloroform layer and centrifuged at 5000 rpm for 10 mts at 4 °C.  Phenol-
ethanol supernatant was added to 1 ml of isopropanol and incubated at room temperature 
for 10 mts.  After incubation, samples were centrifuged at 5000 rpm for 10 mts at 4 °C to 
pellet proteins.  Protein pellets were washed with 0.3 M guanidine hydrochloride in 95% 
ethanol followed by 20 mts incubation at room temperature and centrifugation at 5000 
rpm for 10 mts at 4 °C.  This process was repeated 3 times.  Finally, pellets were 
resuspended in 200 µl of lysis buffer containing protease and phosphatase inhibitors.  
Protein concentration was measured using a BCA protein assay kit.  All samples were 
stored at -80 C until further use. 
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 Western blot analysis:  All samples were diluted to a protein concentration of 4 
μg/μl in loading buffer (62.5 mM Tris, pH 6.8; 2% SDS; 10% glycerol; 2.5%  
mercaptoethanol; and 0.002 bromophenole blue) and heated at 95 C for 5 min.  Protein 
(60 μg; 15 μl) was separated at 80V (through the stacking gel) and then run at 120V for 3 
h in a 4-20% gradient polyacrylamide gel (Lonza, Rockland, ME, USA). Following 
separation, the protein was transferred to a nitrocellulose membrane (GE Water and 
Process Technologies, Feasterfille-Trevose, PA, USA) overnight at 20V at 4°C.  All 
membranes were stained with Ponceau S to verify equal loading and transfer. Membranes 
were blocked for 1 h in 5% milk in Tris-buffered saline with 0.1% Tween 20 (TTBS) and 
incubated with primary antibody diluted in 5% milk in TTBS a 4°C overnight as follows:   
MyHC-/slow (1:500 rabbit polyclonal), MyHC- (1:500 rabbit polyclonal), MyHC-IIa 
(1:500 mouse polyclonal) MyHCIIx (1:500 rabbit polyclonal) (Proteintech, Chicago, IL, 
USA).  The next day, membranes were washed 3 times for 10 min in TTBS and 
incubated with species specific (anti-rabbit IgG horseradish peroxidase or anti-mouse IgG 
horseradish peroxidase) secondary antibodies (1:2000) for 1 h at room temperature.  
Membranes were then washed 3 times for10 min with TTBS.  Following the final wash, 
membranes were incubated in the chemiluminescence detection substrate ECL 
(Millipore) for 5 minutes and emitted light was captured with film. To analyze the protein 
abundance, band density was measured of using ImageJ software (NCBI).  Equal protein 
loading was confirmed by Ponceau S densitometry values.  
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Statistical analysis 
 Muscle performance and functional data were analyzed by two way repeated 
measures ANOVA.  Differences were located using the post hoc Holm-Sidak test using 
SigmaPlot (Version 11.0).  Gene and protein expression data were analyzed by paired t-
tests comparing within group pre-and post-training values.  If normalized gene expression 
data for an individual sample was greater than 2 standard deviations from the mean, the 
sample was excluded as an outlier. Significance was set at P < 0.05.  All data are 
expressed means ± SE. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.  Primer sequences for qPCR 
Gene Forward Primer  Reverse Primer  
MYH1 tctttggtcacctttcagcagt ctggtggacaaactgcaagc 
MYH2 cttcacccgcagtttgttca catgagaggcgagtgaagga 
MYH6 attacaggttggcaagagtgag cggctacaggacctggtggaca  
MYH7 tcaagatgtggcaaagctac acaagctgcagctaaaggtc  
ACTB cgtacaggtctttgcggatg ccctggagaagagctacgag 
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CHAPTER IV  
 
 RESULTS 
 
 
Subjects 
 
 At baseline, there were no differences between HVRT (n = 13) and LVRT (n=13) 
groups in age, gender, height, weight or body mass index (P < 0.05; Table1). There was 
no significant weight gain or loss within groups (P < 0.05).  From baseline to post 
training, there were several significant differences in muscle performance and functional 
characteristics within groups.  These are described below. 
Muscle Performance 
 
Muscle performance results are presented in Table 3 and also described below.  
 
 Peak Torque.  Peak torque values are shown in Figure 1.  Peak torque values in 
LVRT improved significantly at 75 deg/s (P < 0.001) and 180 deg/s (P < 0.05) with no 
significant difference at 240 deg/s (P > 0.05).  Peak torque values in HVRT displayed a 
trend towards significance at 75 deg/s (P = 0.052) and showed significant improvements 
at 180 deg/s (P < 0.01) and 240 deg/s (P < 0.001).  
 Maximal repetition total work.  Maximal repetition total work values are shown in 
Figure 2.  Maximal repetition total work values in LVRT improved significantly at 75 
deg/s (P < 0.05) with no significant difference at 180 deg/s and  240 deg/s (P > 0.05).  
Max rep total work values in HVRT did not improve significantly at 75 deg/s or 180 
deg/s (P > 0.05) and displayed a trend towards significance at 240 deg/s (P = 0.054).    
 Total Work.  Total work values are shown in Figure 3.  Total work values in 
LVRT improved significantly at 75 deg/s (P < 0.001) with no significant difference at 
180 deg/s and 240 deg/s (P > 0.05).  Total work values in HVRT did not improve 
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significantly at 75 deg/s or 180 deg/s (P > 0.05).  Improvements were significant at 240 
deg/s (P < 0.05).    
 Torque at 0.2 seconds.  Torque at 0.2 seconds values are shown in Figure 4.  
Torque at .2 seconds values in LVRT improved significantly at 75 deg/s (P < 0.001) and 
at 180 deg/s (P < 0.01) with no significant difference at 240 deg/s (P > 0.05).  Torque at 
.2 seconds values in HVRT improved significantly at 75 deg/s (P < 0.05), 180 deg/s (P < 
0.05), and 240 deg/s (P < 0.01). 
 Average power.  Average power values are shown in Figure 5.  Average power 
values in LVRT improved significantly at 75 deg/s (P < 0.01) with no significant 
differences at 180 deg/sec and 240 deg/s (P > 0.05).  Average power values in HVRT 
improved significantly at 75 deg/s (P < 0.05), 180 deg/s (P < 0.01), and 240 deg/s (P < 
0.01). 
 Peak Power.  Peak power values are shown in Figure 6.  Peak power values in 
LVRT improved significantly at 75 deg/s (P < 0.001) and at 180 deg/sec (P < 0.05)  with 
no significant differences at 240 deg/s (P > 0.05).  Peak power values in HVRT improved 
significantly at 75 deg/s (P < 0.05), 180 deg/s (P < 0.01), and 240 deg/s (P < 0.001). 
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Fig 1.  Change in peak torque at 75 deg/s, 180 deg/s and 240 deg/s for a LVRT and b 
HVRT groups pre and post 6 weeks of training.  *P < 0.05, **P < 0.01, ***P < 0.001, #P 
=0.052 vs pre-test.   
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Fig 2.  Change in max rep work at 75 deg/s, 180 deg/s and 240 deg/s for a LVRT and b 
HVRT groups pre and post 6 weeks of training.  *P < 0.05, #P = 0.054 vs pre-test.   
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Fig 3.  Change in total work at 75 deg/s, 180 deg/s and 240 deg/s for a LVRT and b 
HVRT groups pre and post 6 weeks of training.  *P < 0.05, ***P < 0.001 vs pre-test.   
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Fig 4.  Change in torque at .2 seconds at 75 deg/s, 180 deg/s and 240 deg/s for a LVRT 
and b HVRT groups pre and post 6 weeks of training.  *P < 0.05, **P < 0.01, ***P < 
0.001 vs pre-test.   
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Fig 5.  Change in average power at 75 deg/s, 180 deg/s and 240 deg/s for a LVRT and b 
HVRT groups pre and post 6 weeks of training.  *P < 0.05, **P < 0.01, vs pre-test.   
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Fig 6.  Change in peak power at 75 deg/s, 180 deg/s and 240 deg/s for a LVRT and b 
HVRT groups pre and post 6 weeks of training.  *P < 0.05, **P < 0.01, ***P < 0.001 vs 
pre-test.   
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Function 
 
 Semi-tandem stand test.   Pre and post intervention results for the semi-tandem 
stand test results are shown in Figure 7.  There were no significant differences between or 
within groups (P > 0.05). 
 Tandem stand test.  Pre and post intervention results for the tandem stand test 
results are shown in Figure 8.  There were no significant differences between or within 
groups (P > 0.05). 
 Usual walking speed.  Pre and post intervention results for usual walking speed 
are shown in Figure 9.  There were no significant differences between or within groups 
(P > 0.05). 
 Maximum walking speed.  Pre and post intervention results for maximum walking 
speed are shown in Figure 10.  Prior to training, maximum walking speed was 
significantly lower in HVRT than LVRT (P < 0.05).  Max walking speed improved 
significantly in both LVRT (P < 0.001) and HVRT (P < 0.05).   
 Sit to stand.  Pre and post intervention results for the sit to stand test are shown in 
Figure 11.  Sit to stand time improved significantly in LVRT (P < 0.001) and HVRT (P < 
0.001) with a trend towards greater improvement in HVRT (P=0.083). 
 Get up and go.  Pre and post intervention results for the get up and go test are 
shown in Figure 12.  Get up and go time improved significantly in LVRT (P < 0.01) and 
HVRT (P < 0.001) with a trend towards greater improvement in HVRT (P=0.056). 
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Fig 7.  Changes in semi-tandem stand test. 
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Fig 8.  Changes in tandem stand test. 
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Fig 9.  Changes in usual walking speed. 
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Fig 10.  Changes in maximum walking speed.  *P < 0.05, ***P < 0.001 vs pre-test. 
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Fig 11.  Changes in sit to stand time.  ***P < 0.001 vs pre-test.  #P = 0.083 between 
groups  
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Fig 12.  Changes in get up and go time.  **P < 0.01, ***P < 0.001 vs pre-test.  #P = 
0.056 between groups 
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Gene expression 
 
 Pre and post intervention results for MyHc-/slow mRNA, MyHc- mRNA, 
MyHc-IIa mRNA, and MyHc-IIx mRNA expression are shown in Figure 13.  MyHc-
/slow mRNA showed no significant change (P > 0.05) within LVRT (n = 5) or HVRT 
(n = 6).  MyHc- mRNA showed a significant (P < 0.01) decrease (.93-fold ± 0.12) in 
LVRT (n = 5) and a significant (P < 0.01) increase (2.0-fold ± .62) in HVRT (n=7).  
MyHc-IIa mRNA showed no significance (P > 0.05) in LVRT (n = 6) and a significant 
(P < 0.05) increase (1.2-fold ± 0.01) in HVRT (n=7).  MyHc-IIx mRNA showed a 
significant (P < 0.01) decrease (0.99-fold ± 0.004) in LVRT (n = 6) with no significant 
change in HVRT (n = 7) (P > 0.05).   
Protein expression 
 
 Pre and post intervention results for MyHc-/slow, MyHc-IIa, and MyHc-IIx 
expression are shown in Figure 14.  MyHc-/slow had no significant (P > 0.05) change in 
LVRT (n = 7, 1.0 ± 0.06 vs 1.15 ± 0.09, pre vs post) with a significant (P < 0.05) 
decrease in HVRT (n = 7, 1.0 ± 0.12 vs 0.84 ± 0.13, pre v post).  MyHc-IIa did not 
change in LVRT (n = 3, 1.0 ± 0.36 vs 2.45 ± 0.52, pre vs post) or in HVRT (n = 4, 1.0 ± 
0.63 vs 0.86 ± 0.31, pre vs post). MyHc-IIx decreased (P < 0.01) in LVRT (n = 7, 1.0 ± 
0.06 vs 0.87 ± 0.06, pre vs post) but not in HVRT (n = 7, 1.0 ± 0.08 vs 1.06 ± 0.13).  
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Fig 13.  Relative changes in MyHC mRNA expression.  *P < 0.05, **P < 0.01, 
significant within group difference.   
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Fig 14.  Relative changes in MyHC expression and  representative Ponceau S stain *P < 
0.05, **P < 0.01, significant within group difference.   
 
 
 
 
 
 
* 
0
0.5
1
1.5
PRE POST PRE POST
LVRT HVRT
R
el
at
iv
e 
E
x
p
re
ss
io
n
  
A.    MyHC-/slow 
0
1
2
3
PRE POST PRE POST
LVRT HVRT
R
el
at
iv
e 
E
x
p
re
ss
io
n
 
B.    MyHC-IIa 
** 
0
0.5
1
1.5
PRE POST PRE POST
LV HV
R
el
at
iv
e 
E
x
p
re
ss
io
n
  
C.    MyHC-IIx 
52 
 
CHAPTER V  
 
 CONCLUSION 
 
 
 
 In the case of older adults, the ability to generate adequate levels of force at high 
movement speeds deteriorates rapidly (Martin et al., 2000; Metter et al., 1997; Mitchell et 
al., 2012).  This decline in muscle function is associated with several unfavorable 
outcomes (Bassey et al., 1992; Bean et al., 2003; Phillips et al., 1998).  This being the 
case, determining which mode of exercise can most effectively slow or reverse losses of 
muscle function with age is essential.  Of equal importance is the ability to identify 
mechanisms which influence how older adults adapt to varying training stimuli.  To our 
knowledge, this is the first study to examine velocity specificity of resistance training by 
directly comparing changes in muscle transcription, translation, performance, and 
function in older adults. 
 Both LVRT and HVRT increased several muscular performance and functional 
measurements.  Supporting recent research, our results demonstrate HVRT provides a 
greater number of muscular enhancements when compared to LVRT, particularly under 
conditions of high velocity muscle contraction (Earles, 2001; Fielding et al., 2002; Marsh 
et al., 2009; Puhke et al., 2006 Sayers et al., 2012 Sayers et al., 2014).  The LVRT group 
showed an overall improvement of 9 strength characteristics at testing velocities of 75 
deg/sec and 180 deg/sec.  The HVRT group showed an overall improvement of 12 
strength characteristics at testing velocities of 180 deg/sec and 240 deg/sec.  While 
statistical significance was not achieved, HVRT displayed a trend (P<0.10) towards 
improvement in 2 additional strength characteristics. These results demonstrate that while 
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velocity-specific training improvements were present in both groups, the HVRT group 
displayed a greater carry over into testing velocities which were not utilized during 
training.  Both groups showed improvements in maximum walking speed, the get up and 
go test, and the sit to stand test.  It is worthy of note, in the get up and go test and the sit 
to stand test there was a trend towards greater improvements in the HVRT group.  This 
trend would be expected as the HVRT group enhanced a greater number of strength 
characteristics which are known to positively influence functional outcomes.  
 The present study further demonstrates that the transcriptional and translational 
events which take place in response to mechanical loading are influenced by the velocity 
of muscle contraction.  In the LVRT group, there was a downregulation of MyHC-IIx 
mRNA and MyHC- mRNA and a decrease in MyHC-IIx at the protein level.  Taken 
together, this suggests that the low velocity training stimulus was inducing a fast-to-slow 
MyHC shift within the muscle.  This finding is in agreement with a number of studies 
investigating MyHC response to exercise (Hortobagyi et al., 2000; Short et al., 2005; 
Staron et al., 1990).  In the HVRT group, there was an upregulation of MyHC- mRNA 
and MyHc-IIa mRNA and a decrease in MyHC-/slow, indicating a slow-to-fast MyHC 
shift.  While some studies have shown a similar phenomenon to take place in younger 
adults (Andersen et al., 1994; Esbjornsson et al., 1993, Jansson et al., 1978; Jansson et al., 
1990; Liu et al., 2003; Malisoux et al., 2006; Paddon-Jones, et al., 2001), this finding is 
novel in older adults.    
 We are not certain why the different movement velocities produced different 
alterations in MyHC mRNA and protein.  However, it is likely motor unit recruitment 
took place in a dissimilar fashion between groups in order to effectively meet the unique 
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mechanical demands being placed on the musculature (Hather et al., 1999; Hortobagyi, et 
al., 1996; Rome et al., 1988).  It is also difficult to discern what exactly lead to the 
different muscle performance and functional outcomes.  It is likely that on the onset of 
training neural adaptations, such as improved intra-and intermuscular coordination, took 
place in both groups (Hortobagyi et al., 1996; Sale et al., 1996).  The HVRT group may 
have experienced additional neurological training effects.  It has been demonstrated 
through electromyography (EMG) that higher velocity movements may lead to earlier 
motor unit activation and higher maximal firing rate (Van Cutsem et al., 1998).  It is 
commonly accepted that after initial strength gains in RT, both neural factors and 
myofibrillar alterations contribute to increases in muscular performance, with 
myofibrillar alterations becoming the dominant factor after 3-5 weeks (Moritani et al., 
1979).   The dissimilar responses seen between groups at the protein level also provide 
insights into the divergent muscle performance outcomes, as changes in MyHC 
composition have been shown to alter whole muscle performance (D’Antona et al., 2006; 
Harridge et al., 1996; Ryushi et al., 1986).    
 With age, skeletal muscle takes on a slow, type-1 phenotype which is associated 
with declines in muscle function (Martin et al., 2000; Pearson et al., 2006).  This 
phenotypic shift is partly due to a decrease in the rate of MyHC-2A and MyHC-2X 
synthesis with age (Blazejowski et al., 1984, Hasten et al., 2000; Welle et al., 1993).  
While it is not a uniform finding, decreases in MyHC-2A mRNA and MyHC-2X mRNA 
are reported with age and provide a logical mechanism underlying the decreased 
synthesis of fast MyHC isoforms (Balagopal et al., 2001; Welle et al., 2000).  In the 
present study, HVRT led to the upregulation of MyHC-IIa mRNA while preserving 
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MyHC-IIx mRNA and protein.  This resulted in HVRT targeting age related declines in 
translation and proposed declines in transcription with greater specificity than LVRT.  
This could partly explain the favorable muscle performance and functional outcomes in 
the HVRT group.    
 As with all research, the present study had several limitations.  If the present study 
had been longer in duration there would have a better understanding of how muscular vs 
neurological enhancements influenced training adaptations.  Also, being able to test for 
single fiber function could have effectively ruled out the nervous system influence and 
informed us if there were improvements in cross bridge contraction kinetics and/or 
mechanical properties.  Additionally, if the study had been longer in duration, we may 
have observed greater changes at the protein level.  The up-or-down regulation of MyHC 
mRNA has been shown to occur rapidly at the onset of training (Jaschinski et al., 1998; 
Nadal-Ginard et al., 1982).  There is a more rapid turnover of MyHC mRNAs, compared 
with the slow turnover of the corresponding proteins (Gupta et al., 1992; Russell et al., 
1992).  This delay is thought to be caused by the disassembling of older filaments before 
newly synthesized isoforms are introduced into the sarcomere (Brown et al., 1989; 
Eisenberg et al., 1984).  While the MyHC mRNA response to training has been shown to 
be indicative of, and at times mirror, subsequent alterations in MyHC protein expression 
(Andersen et al., 1997; Jaschinski et al., 1998; Marx et al., 2002), a longer training period 
would have provided more time for MyHC isoforms to respond to the training stimulus 
and to be present in the sarcomere.  Also, having a greater amount of subjects to take 
biopsies from would have helped in the statistical analysis of these results.  There was a 
large amount of variability surrounding gene expression and MyHC-IIa protein could not 
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be detected in all the samples.  This variability could be due to a host of genetic and 
environmental influences (Simoneau et al., 1995).  Future studies should employ a longer 
training stimulus with a larger sample size in order to gain a better understanding of 
neurological vs. muscular enhancements, and to better determine how MyHC responds to 
HVRT at the protein level.    
 In conclusion, HVRT is emerging as the optimal training stimulus for the older 
adult.  The present study demonstrates, in addition to increased muscular performance 
and functional outcomes, HVRT may also evoke a favorable (i.e., slow-to-fast) 
transcriptional and translational response in MyHC.   
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